Morgens Waterfall Vintiadis & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Morgens Waterfall Vintiadis & Co's GILD Position: Q1 2025 in Review
Morgens Waterfall Vintiadis & Co sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 40,000 shares — an estimated $3.69M sold.
Morgens Waterfall Vintiadis & Co first reported a position in GILD in Q2 2013 and held it in 15 quarters. The position peaked at $9.32M in Q1 2015. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.
- Morgens Waterfall Vintiadis & Co reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
- Morgens Waterfall Vintiadis & Co sold 40,000 Gilead Sciences shares in Q1 2025, an estimated $3.69M.
- Morgens Waterfall Vintiadis & Co first reported a position in Gilead Sciences in Q2 2013 and held it in 15 quarters.
- Morgens Waterfall Vintiadis & Co's Gilead Sciences position peaked at $9.32M in Q1 2015.
- 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.
Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q1 2025, filed 15 May 2025.